Madrigal’s Rezdiffra off to strong start, but ‘bumpiness’ is coming: analyst kdunleavy Wed, 08/07/2024 – 15:03 More: Madrigal's Rezdiffra off to strong start, but 'bumpiness' is coming: analyst Source: fierce
read moreAfter sharp declines, Merck KGaA and analysts share optimism about potential CDMO rebound fkansteiner Wed, 08/07/2024 – 14:22 More: After sharp declines, Merck KGaA and analysts share optimism about potential CDMO rebound Source: fierce
read moreGenentech, ADA plot program to improve diabetes-related eye health in underserved D.C. communities apark Wed, 08/07/2024 – 11:21 More: Genentech, ADA plot program to improve diabetes-related eye health in underserved D.C. communities Source: fierce
read moreWith Wegovy supplies back on tap, Novo Nordisk’s obesity med doubles US prescriptions from start of year fkansteiner Wed, 08/07/2024 – 11:17 More: With Wegovy supplies back on tap, Novo Nordisk's obesity med doubles US prescriptions from start of year
read morePharmacosmos picks up G1 Therapeutics, FDA-approved drug Cosela in merger worth $405M zbecker Wed, 08/07/2024 – 10:56 More: Pharmacosmos picks up G1 Therapeutics, FDA-approved drug Cosela in merger worth 5M Source: fierce
read more
Researchers aim to explore and investigate axonal dysfunction in neurodegeneration More: MRC and MND Association award £3.9m to KCL and UCL for ALS/FTD research Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals